Account Info
Log Out
English
Back
No matches yet
Operations too frequent. Please try again later.
Please check network settings and try again Refresh Refresh
Loading
History record delete
    Quotes All >
      News All >
        Log in to access Online Inquiry
        Back to the Top

        $Pacira BioSciences(PCRX.US)$ On October 12, Pacira BioScien...

        $Pacira BioSciences(PCRX.US)$ $Flexion Therapeutics Inc(FLXN.US)$ On October 12, Pacira BioSciences announced that it has entered into a definitive agreement to acquire Flexion Therapeutics For $8.50 per share, or approximately $430 million, in cash to enhance its non-opioid pain portfolio. The deal also includes contingent valuable rights worth up to $8.00 per share, which are tied to Zilretta sales targets and FDA approvals for FX201 and FX301.
        Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
        3
        +0
        Translate
        Report
        3328 Views
        Comment
        Sign in to post a comment
          365Followers
          22Following
          893Visitors
          Follow